Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Diabetic neuropathy treatment market 2020


Published on

Global Diabetic Neuropathy Treatment Market is expected to cross USD 5.80 Billion by 2025 at a CAGR of 5.1%.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Diabetic neuropathy treatment market 2020

  1. 1. Diabetic Neuropathy Treatment Market 2020-2025 Industry Survey, Growth, Competitive Landscape and Forecasts to 2025 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd
  2. 2. www.marketresearchfuture.com2 Diabetic Neuropathy Treatment Market 2020-2025 Diabetic Neuropathy Treatment Market Highlights According to MRFR analysis, the global diabetic neuropathy treatment market is expected to register a CAGR of 5.1% during the forecast period of 2019 to 2025 and was valued at USD 5.80 Billion by 2025. Diabetic neuropathy is one of the most common complications of diabetes. Patients suffering from diabetic neuropathy often report burning pain in foot. The rising prevalence of diabetic neuropathy can be seen worldwide. Around 83% people in the US are suffering from diabetic neuropathy. According to Japanese study around 298 people were diagnosed with diabetic neuropathy in 2017. The growth of the global diabetic neuropathy treatment market is driven by various factors such as an increasing global geriatric population, rising prevalence of diabetes, and poor fitness levels. However, high costs of surgery are expected to curb the growth of the global diabetic neuropathy treatment market.
  3. 3. www.marketresearchfuture.com3 Diabetic Neuropathy Treatment Market 2020-2025 The market has been divided, by region, into the Americas, Europe, Asia- Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of diabetic neuropathy and rising per capita healthcare expenditure. The diabetic neuropathy treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European diabetic neuropathy treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The diabetic neuropathy treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Browse Complete Report with TOC @ https://www.marketresearc 8359 Diabetic Neuropathy Treatment Market Regional Analysis
  4. 4. www.marketresearchfuture.com4 Diabetic Neuropathy Treatment Market 2020-2025 The global diabetic neuropathy treatment market has been segmented based on disorder, treatment, and end user. The market, based on disorder, has been divided into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. The peripheral neuropathy segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of peripheral neuropathy globally. Around 1.3 million Americans are diagnosed with peripheral neuropathy every year. The autonomic neuropathy segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population. The global diabetic neuropathy treatment market has been segmented, on the basis of treatment, into drugs, transcutaneous electrical nerve stimulation (TENS), and others. The drugs segment is expected to hold the majority share of the market. The drugs help increase muscle strength and quicken the recovery process. Diabetic Neuropathy Treatment Market Segmental Analysis
  5. 5. www.marketresearchfuture.com5 Diabetic Neuropathy Treatment Market 2020-2025 Diabetic Neuropathy Treatment Market Key Players • Abbott Laboratories (US) • F. Hoffmann-La Roche Ltd (Switzerland) • Eli Lilly and Company (US) • Johnson & Johnson (US) • GlaxoSmithKline Plc (UK) • Lupin Limited (India) • Glenmark Pharmaceuticals Limited (India) • Depomed, Inc (US) • Astellas Pharma Inc (Japan) • Pfizer Inc (US) Avail Free Sample @ https://www.marketresearchfuture. com/sample_request/8359
  6. 6. www.marketresearchfuture.com6 ABOUT US MARKETRESEARCHFUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports(HCRR), Raw ResearchReports(3R),Continuous-FeedResearch(CFR),andMarket Research& ConsultingServices. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help toansweralltheirmost importantquestions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Formore informationkindlyvisit www.marketresearchfuture.comor contactus at Copyright © 2018Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwisereproducedwithout thewritten approvalof Market ResearchFuture.
  7. 7. www.marketresearchfuture.com7 MARKET RESEARCH FUTURE THANK YOU Ph:+1-646-845-9349(US) Ph:+44 208133 9349(UK)